{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:47:55Z","timestamp":1790376475576,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-2037-8","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T10:18:55Z","timestamp":1451384335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1"],"prefix":"10.1186","volume":"15","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Canal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurianne","family":"Lescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Del Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Camonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ragazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"issue":"1","key":"2037_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.gde.2010.10.009","volume":"21","author":"R Brough","year":"2011","unstructured":"Brough R, Frankum JR, Costa-Cabral S, Lord CJ, Ashworth A. Searching for synthetic lethality in cancer. Curr Opin Genet Dev. 2011;21(1):34\u201341.","journal-title":"Curr Opin Genet Dev"},{"issue":"9","key":"2037_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrc1691","volume":"5","author":"WG Kaelin Jr","year":"2005","unstructured":"Kaelin Jr WG. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer. 2005;5(9):689\u201398.","journal-title":"Nat Rev Cancer"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1741-7015-10-25","volume":"10","author":"S Kummar","year":"2012","unstructured":"Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, et al. Advances in using PARP inhibitors to treat cancer. BMC Med. 2012;10:25.","journal-title":"BMC Med"},{"issue":"3","key":"2037_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46(3):740\u20138.","journal-title":"Hepatology"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2741\/2076","volume":"12","author":"W Lau de","year":"2007","unstructured":"de Lau W, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci. 2007;12:471\u201391.","journal-title":"Front Biosci"},{"issue":"15","key":"2037_CR6","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","volume":"95","author":"A Coste de La","year":"1998","unstructured":"de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A. 1998;95(15):8847\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2037_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cellsig.2013.11.032","volume":"26","author":"M Krausova","year":"2014","unstructured":"Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26(3):570\u20139.","journal-title":"Cell Signal"},{"issue":"4","key":"2037_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/138161213804581837","volume":"19","author":"A Voronkov","year":"2013","unstructured":"Voronkov A, Krauss S. Wnt\/beta-catenin signaling and small molecule inhibitors. Curr Pharm Des. 2013;19(4):634\u201364.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"2037_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.embor.embor865","volume":"4","author":"M Wetering van de","year":"2003","unstructured":"van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 2003;4(6):609\u201315.","journal-title":"EMBO Rep"},{"issue":"6","key":"2037_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/1087057103258285","volume":"8","author":"C Brideau","year":"2003","unstructured":"Brideau C, Gunter B, Pikounis B, Liaw A. Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen. 2003;8(6):634\u201347.","journal-title":"J Biomol Screen"},{"issue":"2","key":"2037_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nbt1186","volume":"24","author":"N Malo","year":"2006","unstructured":"Malo N, Hanley JA, Cerquozzi S, Pelletier J, Nadon R. Statistical practice in high-throughput screening data analysis. Nat Biotechnol. 2006;24(2):167\u201375.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2037_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nmeth.1351","volume":"6","author":"A Birmingham","year":"2009","unstructured":"Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods. 2009;6(8):569\u201375.","journal-title":"Nat Methods"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1476-4598-8-90","volume":"8","author":"H Yuzugullu","year":"2009","unstructured":"Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer. 2009;8:90.","journal-title":"Mol Cancer"},{"issue":"26","key":"2037_CR14","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.261574498","volume":"98","author":"D Yan","year":"2001","unstructured":"Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt\/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A. 2001;98(26):14973\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2037_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22(4):1172\u201383.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2037_CR16","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. Embo J. 2012;31(12):2714\u201336.","journal-title":"Embo J"},{"issue":"12","key":"2037_CR17","doi-asserted-by":"publisher","first-page":"8265","DOI":"10.1073\/pnas.082240999","volume":"99","author":"TA Chan","year":"2002","unstructured":"Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW. Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. Proc Natl Acad Sci U S A. 2002;99(12):8265\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"2037_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drudis.2010.11.007","volume":"16","author":"F Verkaar","year":"2011","unstructured":"Verkaar F, Zaman GJ. New avenues to target Wnt\/beta-catenin signaling. Drug Discov Today. 2011;16(1-2):35\u201341.","journal-title":"Drug Discov Today"},{"issue":"8","key":"2037_CR19","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1182\/blood-2009-09-243980","volume":"115","author":"RE Tiedemann","year":"2010","unstructured":"Tiedemann RE, Zhu YX, Schmidt J, Yin H, Shi CX, Que Q, et al. Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood. 2010;115(8):1594\u2013604.","journal-title":"Blood"},{"issue":"5","key":"2037_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ncb791","volume":"4","author":"C Raiborg","year":"2002","unstructured":"Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, Stenmark H. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol. 2002;4(5):394\u20138.","journal-title":"Nat Cell Biol"},{"issue":"13","key":"2037_CR21","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/sj.emboj.7600688","volume":"24","author":"AC Hanyaloglu","year":"2005","unstructured":"Hanyaloglu AC, McCullagh E, von Zastrow M. Essential role of Hrs in a recycling mechanism mediating functional resensitization of cell signaling. Embo J. 2005;24(13):2265\u201383.","journal-title":"Embo J"},{"issue":"11","key":"2037_CR22","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1158\/0008-5472.CAN-06-2756","volume":"67","author":"M Toyoshima","year":"2007","unstructured":"Toyoshima M, Tanaka N, Aoki J, Tanaka Y, Murata K, Kyuuma M, et al. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin. Cancer Res. 2007;67(11):5162\u201371.","journal-title":"Cancer Res"},{"issue":"12","key":"2037_CR23","doi-asserted-by":"publisher","first-page":"e28338","DOI":"10.1371\/journal.pone.0028338","volume":"6","author":"DF Gilbert","year":"2011","unstructured":"Gilbert DF, Erdmann G, Zhang X, Fritzsche A, Demir K, Jaedicke A, et al. A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS One. 2011;6(12):e28338.","journal-title":"PLoS One"},{"issue":"10","key":"2037_CR24","first-page":"2744","volume":"62","author":"JS Kim","year":"2002","unstructured":"Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, et al. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 2002;62(10):2744\u20138.","journal-title":"Cancer Res"},{"issue":"12","key":"2037_CR25","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1158\/1078-0432.CCR-04-1162","volume":"11","author":"A Koch","year":"2005","unstructured":"Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Wharton Jr KA, et al. Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin Cancer Res. 2005;11(12):4295\u2013304.","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2037_CR26","doi-asserted-by":"publisher","first-page":"14438","DOI":"10.1074\/jbc.M109.052001","volume":"285","author":"W Qiu","year":"2010","unstructured":"Qiu W, Hu Y, Andersen TE, Jafari A, Li N, Chen W, et al. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C\/EBP. J Biol Chem. 2010;285(19):14438\u201349.","journal-title":"J Biol Chem"},{"issue":"6","key":"2037_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1349-7006.2008.00814.x","volume":"99","author":"Y Torisu","year":"2008","unstructured":"Torisu Y, Watanabe A, Nonaka A, Midorikawa Y, Makuuchi M, Shimamura T, et al. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin\/TCF. Cancer Sci. 2008;99(6):1139\u201346.","journal-title":"Cancer Sci"},{"issue":"7","key":"2037_CR28","doi-asserted-by":"publisher","first-page":"E1206","DOI":"10.1210\/jc.2010-2143","volume":"96","author":"J Durand","year":"2011","unstructured":"Durand J, Lampron A, Mazzuco TL, Chapman A, Bourdeau I. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations. J Clin Endocrinol Metab. 2011;96(7):E1206\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7165","key":"2037_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003\u20137.","journal-title":"Nature"},{"issue":"10","key":"2037_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1515\/hsz-2012-0130","volume":"393","author":"E Zeller","year":"2012","unstructured":"Zeller E, Mock K, Horn M, Colnot S, Schwarz M, Braeuning A. Dual-specificity phosphatases are targets of the Wnt\/beta-catenin pathway and candidate mediators of beta-catenin\/Ras signaling interactions. Biol Chem. 2012;393(10):1183\u201391.","journal-title":"Biol Chem"},{"issue":"6726","key":"2037_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422\u20136.","journal-title":"Nature"},{"issue":"3","key":"2037_CR32","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-05-3694","volume":"66","author":"ND Hendrix","year":"2006","unstructured":"Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006;66(3):1354\u201362.","journal-title":"Cancer Res"},{"issue":"5382","key":"2037_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509\u201312.","journal-title":"Science"},{"issue":"2","key":"2037_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.immuni.2006.12.007","volume":"26","author":"B Wu","year":"2007","unstructured":"Wu B, Crampton SP, Hughes CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity. 2007;26(2):227\u201339.","journal-title":"Immunity"},{"issue":"5435","key":"2037_CR35","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1126\/science.285.5435.1923","volume":"285","author":"J Roose","year":"1999","unstructured":"Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, et al. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999;285(5435):1923\u20136.","journal-title":"Science"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-2037-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-2037-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-2037-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T17:37:47Z","timestamp":1475775467000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-2037-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-2037-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"1020"}}